29 Apr 2020
Steve Powell is a renowned, international expert with a career spanning over 30 years within pharmaceutical technology. He has worked for organisations such as GSK and Phase Forward and now has a number of NED and Chair positions supporting technology businesses across eCOA, late phase, informatics and pharmacovigilance. In this podcast, Steve discusses the possible implications of Covid-19 on the pharmaceutical technology sector.
Listen to the Podcast below:
Services
Services
9 Greyfriars Road,
Reading,
Berkshire,
RG1 1NU
t: +44 (0)118 935 9444
e: info@spencergroup.com
Website by Supreme